NEVVI Medicare utilization intelligence
or

← back

Provider profile

LI, HENRY M.D.

Hematology-Oncology · NPI 1831166024 · SEATTLE, WA

1
Groups
40
Codes · 2024
135,569
Disclosed services

LI, HENRY is a Hematology-Oncology in SEATTLE, WA, a member of 1 medical group, who billed 40 distinct codes to Medicare Part B in 2024.

Groups: THE POLYCLINIC PLLC (SEATTLE, WA)

Year: 2024 · 2023 · 2022 🔒 · 2021 🔒 · 2020 🔒

Provider overview · all codes · CY2024

135,569
disclosed services
40
codes billed to Medicare Part B
Prior year · CY2023 114,283 disclosed services

This provider's disclosed Medicare payments across all codes were in CY2024.

Dollars, place-of-service mix, business mix and national standing are part of the market analytics platform — built, not launched yet. Notify me at launch →

All figures are disclosed (CMS suppresses fewer-than-11-beneficiary rows) Medicare Part B fee-for-service — a subset, never complete totals; volumes are personal to this NPI, not attributed to any group. Standing is a billed-volume position among specialty peers with disclosed billing (national percentile; a provider's true standing can only be higher, never lower), not a statement about care. See Methods & Sources.

Procedures billed to Medicare Part B (2024)

Medicare Part B FFS · CY2024 · as published by CMS
This provider's Medicare volumes — services, beneficiary-episodes, and charges — are part of the market analytics platform — built, not launched yet. Notify me at launch →
CodeDescription Services Beneficiary-episodes Avg charge Avg Medicare payment
J3262 Injection, tocilizumab, 1 mg
J0881 Injection, darbepoetin alfa, 1 microgram (non-esrd use)
Q0138 Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use)
J1568 Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg
J1602 Injection, golimumab, 1 mg, for intravenous use
J1745 Injection, infliximab, excludes biosimilar, 10 mg
J0129 Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)
J0897 Injection, denosumab, 1 mg
J2919 Injection, methylprednisolone sodium succinate, 5 mg
36415 Insertion of needle into vein for collection of blood sample
85025 Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count
80053 Blood test, comprehensive group of blood chemicals
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
96365 Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less
J1100 Injection, dexamethasone sodium phosphate, 1 mg
96413 Administration of chemotherapy into vein, 1 hour or less
96372 Injection of drug or substance under skin or into muscle
99213 Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
96375 Injection of additional new drug or substance into vein
96366 Infusion into a vein for therapy, prevention, or diagnosis, each additional hour
82378 Carcinoembryonic antigen (cea) protein level
J3489 Injection, zoledronic acid, 1 mg
96401 Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle
83615 Lactate dehydrogenase (enzyme) level
J1200 Injection, diphenhydramine hcl, up to 50 mg
96415 Administration of chemotherapy into vein, each additional hour
82728 Ferritin (blood protein) level
82784 Gammaglobulin (immune system protein) measurement
99215 Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more
J7050 Infusion, normal saline solution, 250 cc
J9217 Leuprolide acetate (for depot suspension), 7.5 mg
96367 Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less
83735 Magnesium level
83540 Iron level
83550 Iron binding capacity
84153 Psa (prostate specific antigen) measurement, total
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg
84443 Blood test, thyroid stimulating hormone (tsh)
85045 Red blood count, automated test
82607 Cyanocobalamin (vitamin b-12) level

These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.